Pfizer, Allergan Call Off Merger After ‘Inversion’ Tax Rule Change
Pfizer will pay Allergan $150 million for costs, fees and expenses in connection with the failed merger. It said both parties released each other from subsequent legal claims.
Pfizer did not specify what tax law changes killed the merger, but...
To view the full article, register now.